Icon ICLR
NASDAQ ICLR
$169.68 -4.26 (-2.45%)
At close: Sep 17, 2026 · 4:00 PM EDT

Icon (ICLR) Cash & Current Investments (2009 - 2026)

Icon's (ICLR) quarterly Cash & Current Investments came in at $928.4 million in Q2 2026, up 137.81% year-over-year from $390.4 million in Q2 2025, and up 21.33% quarter-over-quarter from $765.2 million in Q1 2026.

Analysis

Icon (ICLR) Cash & Current Investments (2009 - 2026) Analysis & Trends

Icon (ICLR) has reported Cash & Current Investments for 18 consecutive years, with $928.4 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Cash & Current Investments rose 137.81% year-over-year to $928.4 million in Q2 2026; TTM through Jun 2026 was $928.4 million, a 137.81% increase from a year earlier, with the FY2025 full-year figure at $729.3 million, up 22.22% from the prior year.
  • Cash & Current Investments was $928.4 million for Q2 2026 at Icon, up from $765.2 million in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $928.4 million in Q2 2026 and troughed at $271.8 million in Q2 2023.
  • A 5-year average of $520.2 million and a median of $516.6 million in 2024 frame the typical range for Cash & Current Investments.
  • Across the five-year window, Cash & Current Investments slumped 58.52% in 2022 and surged 137.81% in 2026, its largest moves.
  • Over 5 years, Cash & Current Investments stood at $321.4 million in 2022, then advanced by 18.25% to $380.1 million in 2023, then soared by 57.01% to $596.7 million in 2024, then grew by 22.22% to $729.3 million in 2025, then climbed by 27.29% to $928.4 million in 2026.
  • The last three Cash & Current Investments figures came in at $928.4 million (Q2 2026), $765.2 million (Q1 2026), and $729.3 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn 2.08 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn 502.69 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn 928.39 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn 192.03 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn 168.60 Mn
6 Evotec SE 574.75 Mn 148.87 Mn - 425.88 Mn
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn 84.54 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn 4.40 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn 5.47 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 928.39 Mn
Mar 31, 2026 765.16 Mn
Dec 31, 2025 729.35 Mn
Sep 30, 2025 468.89 Mn
Jun 30, 2025 390.40 Mn
Mar 31, 2025 526.70 Mn
Dec 31, 2024 596.73 Mn
Sep 30, 2024 695.51 Mn
Jun 30, 2024 506.55 Mn
Mar 31, 2024 398.04 Mn
Dec 31, 2023 380.06 Mn
Sep 30, 2023 315.02 Mn
Jun 30, 2023 271.83 Mn
Mar 31, 2023 281.53 Mn
Dec 31, 2022 321.40 Mn
Sep 30, 2022 610.87 Mn
Jun 30, 2022 616.63 Mn
Mar 31, 2022 560.81 Mn
Dec 31, 2021 774.81 Mn
Sep 30, 2021 1.01 Bn